If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
Zacks.com on MSN4d
Vertex (VRTX) Surges 5.3%: Is This an Indication of Further Gains?Vertex (VRTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $470.37, marking a +1.88% move from the previous day.
AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...
AbbVie, Vertex Pharmaceuticals, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
The US Food and Drug Administration has approved suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid ...
A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...
HealthDay on MSN2d
FDA Approves First New Non-Opioid Pain Pill in DecadesThe US FDA has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback